Menu ×


Soft Tissue Allografts Market Analysis by Type (Cartilage Allograft, Tendon Allograft, Meniscus Allograft, Dental Allograft, Collagen Allograft, and Amniotic Allograft); by Application (Orthopedic, Dentistry, Wound Care, and Others); and by End-User (Hospitals, Orthopedic Clinics, Aesthetic Centers, Dental Clinics, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2022-2031

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More


  • August 15th, 2022: Organogenesis Inc. received the 510k clearance for PuraPly MZ for complex surgical wounds from the U.S. Food and Drug Administration (FDA).

  • April 16th, 2019: RTI Surgical, Inc. and Zimmer Biomet partnered with the American Academy of Implant Dentistry Foundation (AAIDF) to provide dental implants and wound care products for an initiative supporting veterans of the United States Armed Forces.

Global Soft Tissue Allografts Market Size, Forecast, and Trend Highlights Over 2022 - 2031

Soft Tissue Allografts Market Forecast Chart

The global soft tissue allografts market is estimated to garner a revenue of ~USD 7 Billion by the end of 2031 by growing at a CAGR of ~7% over the forecast period, i.e., 2022 – 2031. Further, the market generated a revenue of ~USD 4 Billion in the year 2021. The growth of the market is primarily attributed to the increasing trauma cases, and rising number of geriatric population. As per the World Health Organization (WHO), globally, the number of people over the age of 60 is projected to reach 1.4 billion by 2030.

Soft Tissue Allografts Market Overview Chart

Get more information on this report: Request Sample PDF

Allograft tissue is a tissue that has surgically implanted from one person to another. Soft tissue allografts are the replacement tissues used in anterior cruciate ligament (ACL) to repair damaged ligament, torn menisci, osteochondral defects, and spinal surgery. Utilization of allografts for soft tissue reconstruction results in less donor tissue site mortality and relatively short surgical time. Therefore, the increasing count of anterior cruciate ligament (ACL) sprains and tears is fueling up the growth of the soft tissue allografts market. For instance, in the United States, the prevalence rate of ACL sprains and tears ranges from 110,000 to 226,000 per year.

Global Soft Tissue Allografts Market: Growth Drivers and Challenges

Growth Drivers

  • Growing Incidences of Sports Injuries - Sports injuries happen when exercising or playing a sport. These injuries affect the bones, muscles, tendons, ligaments, and other body structures. As per a report, in the United States, every year, approximately 4 million kids aged 14 and under suffer injuries while playing sports or engaging in leisure activities.
  • Rising Prevalence of Osteoarthritis - Older people have a higher risk to develop osteoarthritis. The breakdown of cartilage, a stretchy material that reduces the friction in joints, causes primary osteoarthritis. For instance, around 3 to 6% of people worldwide suffer from osteoarthritis. It is a cause of moderate to severe impairment in nearly 44 million people.
  • Increase in Trauma Cases – As per the World Health Organization, every year, approximately 1.3 million people's lives are ended prematurely as an outcome of a road accident. Non-fatal injuries affect between 20 and 50 million people who have become disabled as a consequence of their injury.
  • Upsurge in Musculoskeletal Diseases – Nearly 1.71 billion people around the world have musculoskeletal diseases.
  • Escalating Per Capita Income – According to the World Bank, in 2021, global annual per capita revenue increased by 4.8%, compared to 1.5% in 2019.


  • High Cost of Treatment
  • Unfavorable Compensation Policies
  • Lack of Skilled Personnel

The global soft tissue allografts market is segmented and analyzed for demand and supply by application into orthopedic, dentistry, wound care, and others, out of which, dentistry segment is estimated to significantly grow over the forecast period owing to the rising number of tooth loss in aging population, and tooth related issues i.e., replacement of missing teeth in people that require an effective treatment. For instance, until 2019, around 4 million people in the United States alone had dental implants, and this number is expanding by 520,000 annually.

Major Macro-Economic Indicators Impacting the Market Growth

Soft Tissue Allografts Market Growth ChartAccording to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Soft Tissue Allografts Market Regional Synopsis

Regionally, the global soft tissue allografts market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America is projected to hold the largest market share by the end of 2031 backed by the rising prevalence of diabetic foot ulcers, growing number of anterior cruciate ligament (ACL) surgical procedures, and rising healthcare expenditure in the region. As per the data provided by the Centers for Medicare & Medicaid Services, healthcare spending in the United States is expected to ascend 5.1% between 2021 to 2030, reaching nearly USD 6.8 trillion by 2030.

Soft Tissue Allografts Market Chart

Get more information on this report: Request Sample PDF

The global soft tissue allografts market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global soft tissue allografts market includes the following segments:

By Type

  • Cartilage Allograft
  • Tendon Allograft
  • Meniscus Allograft
  • Dental Allograft
  • Collagen Allograft
  • Amniotic Allograft

By Application

  • Orthopedic
  • Dentistry
  • Wound Care
  • Others

By End-User

  • Hospitals
  • Orthopedic Clinics
  • Aesthetic Centers
  • Dental Clinics
  • Others

Top Featured Companies Dominating the Global Soft Tissue Allografts Market

  • Stryker Corporation
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • CONMED Corporation
  • LifeSciences Corporation
  • Organogenesis Inc.
  • RTI Surgical, Inc.
  • MIMEDX, Inc.
  • Xtant Medical Holdings, Inc.
  • Globus Medical, Inc.
  • Bone Bank Allografts


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions | LOB

Copyright © 2022 Research Nester. All Rights Reserved